XML 23 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income (loss) $ (1,913,000) $ 13,279,000 $ 13,690,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation and amortization 6,524,000 6,945,000 6,786,000
Deferred income tax expense (benefit) (545,000) 1,420,000 2,660,000
Impairment of intangible assets 5,149,000 0 0
Amortization of deferred costs 40,000 103,000 51,000
Compensation expense related to restricted stock awards 2,221,000 2,129,000 2,201,000
(Gain) loss on sale of assets (1,247,000) 112,000 61,000
(Gain) on insurance claims (233,000) (16,000) (23,000)
Barter (revenue) expense, net (133,000) (190,000) 107,000
Deferred and other compensation 463,000 (634,000) 62,000
Changes in assets and liabilities:      
(Increase) decrease in receivables and prepaid expenses 3,016,000 (5,780,000) (157,000)
Increase (decrease) in accounts payable, accrued expenses, and other liabilities (1,254,000) 7,967,000 121,000
Total adjustments 14,001,000 12,056,000 11,869,000
Net cash provided by operating activities 12,088,000 25,335,000 25,559,000
Cash flows from investing activities:      
Acquisition of property and equipment (2,314,000) (5,732,000) (5,922,000)
Acquisition of broadcast properties (190,000) (763,000) (9,289,000)
Proceeds from sale and disposal of assets 1,691,000 270,000 318,000
Proceeds from insurance claims 233,000    
Other investing activities (24,000) (10,000) 17,000
Net cash used in investing activities (604,000) (6,235,000) (14,876,000)
Cash flows from financing activities:      
Cash dividends paid (3,716,000) (8,623,000) (11,864,000)
Payments on long-term debt   (10,000,000) (5,000,000)
Payments for debt issuance costs     (120,000)
Purchase of treasury shares (449,000) (1,172,000) (2,000,000)
Net cash used in financing activities (4,165,000) (19,795,000) (18,984,000)
Net increase (decrease) in cash and cash equivalents 7,319,000 (695,000) (8,301,000)
Cash and cash equivalents, beginning of period 44,034,000 44,729,000 53,030,000
Cash and cash equivalents, end of period $ 51,353,000 $ 44,034,000 $ 44,729,000